Atterx Biotherapeutics

Atterx Biotherapeutics

Therapeutics to fight the growing epidemic of antibiotic resistant bacteria.
  • Edit
DateInvestorsAmountRound
-

N/A

-

$3.3m

Debt

$1.9m

Debt
N/A

$600k

Convertible
N/A

$375k

Debt

N/A

Series C
Total Funding€545k

Recent News about Atterx Biotherapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.